Status: Phase 3
Entry Type: Antibody
Molecule Category: UNKNOWN

Indications

Mesh Heading Maximum Phase Reference
Sarcoma; Sarcoma, Ewing Phase 1/Phase 2 ClinicalTrials
Neoplasms; Sarcoma Phase 1 ClinicalTrials
Sarcoma, Ewing Phase 1 ClinicalTrials
Breast Neoplasms Phase 2 ClinicalTrials
Neoplasms Phase 1 ClinicalTrials
Carcinoma, Non-Small-Cell Lung Phase 3 ClinicalTrials
Prostatic Neoplasms Phase 2 ClinicalTrials
Carcinoma, Non-Small-Cell Lung Phase 1 ClinicalTrials
Neoplasms Phase 1 ClinicalTrials
Multiple Myeloma; Neoplasms, Plasma Cell Phase 1 ClinicalTrials
Breast Neoplasms Phase 2 ClinicalTrials
Carcinoma Phase 2 ClinicalTrials
Carcinoma, Non-Small-Cell Lung; Lung Neoplasms Phase 1/Phase 2 ClinicalTrials
CONTENTS